ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 13 filers reported holding ANEBULO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,700 | +344.3% | 20,851 | +241.8% | 0.00% | – |
| Q2 2023 | $14,337 | +95480.0% | 6,101 | +19.5% | 0.00% | – |
| Q1 2023 | $15 | +66.7% | 5,107 | +42.0% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 3,597 | -50.9% | 0.00% | – |
| Q3 2022 | $21,000 | -43.2% | 7,330 | +2.6% | 0.00% | -100.0% |
| Q2 2022 | $37,000 | +640.0% | 7,141 | +844.6% | 0.00% | – |
| Q1 2022 | $5,000 | – | 756 | +1838.5% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 39 | -75.3% | 0.00% | – |
| Q2 2021 | $1,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $15,477,516 | 11.03% |
| LVW Advisors, LLC | 672,331 | $2,053,972 | 0.42% |
| Praetorian PR LLC | 177,292 | $541,627 | 0.28% |
| Nantahala Capital Management | 511,073 | $1,561,328 | 0.13% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $1,219,614 | 0.09% |
| Ikarian Capital, LLC | 157,862 | $503,580 | 0.06% |
| Tower Research Capital LLC (TRC) | 20,851 | $63,700 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $57,978 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 22,344 | $68,261 | 0.00% |